JP2000506837A5 - - Google Patents

Download PDF

Info

Publication number
JP2000506837A5
JP2000506837A5 JP1997530600A JP53060097A JP2000506837A5 JP 2000506837 A5 JP2000506837 A5 JP 2000506837A5 JP 1997530600 A JP1997530600 A JP 1997530600A JP 53060097 A JP53060097 A JP 53060097A JP 2000506837 A5 JP2000506837 A5 JP 2000506837A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997530600A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000506837A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP1997/000938 external-priority patent/WO1997031937A1/en
Publication of JP2000506837A publication Critical patent/JP2000506837A/ja
Publication of JP2000506837A5 publication Critical patent/JP2000506837A5/ja
Ceased legal-status Critical Current

Links

JP9530600A 1996-03-01 1997-02-26 セリンプロテアーゼ阻害剤 Ceased JP2000506837A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96200543.5 1996-03-01
EP96200543 1996-03-01
PCT/EP1997/000938 WO1997031937A1 (en) 1996-03-01 1997-02-26 Serine protease inhibitors

Publications (2)

Publication Number Publication Date
JP2000506837A JP2000506837A (ja) 2000-06-06
JP2000506837A5 true JP2000506837A5 (enExample) 2004-11-25

Family

ID=8223736

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9530600A Ceased JP2000506837A (ja) 1996-03-01 1997-02-26 セリンプロテアーゼ阻害剤

Country Status (25)

Country Link
US (1) US6410684B1 (enExample)
EP (1) EP0886647B1 (enExample)
JP (1) JP2000506837A (enExample)
KR (1) KR19990087415A (enExample)
CN (1) CN1212704A (enExample)
AR (1) AR006310A1 (enExample)
AT (1) ATE221080T1 (enExample)
AU (1) AU709330B2 (enExample)
BR (1) BR9707808A (enExample)
CA (1) CA2246246A1 (enExample)
CZ (1) CZ277898A3 (enExample)
DE (1) DE69714222T2 (enExample)
DK (1) DK0886647T3 (enExample)
ES (1) ES2180933T3 (enExample)
HU (1) HUP9900390A3 (enExample)
IL (1) IL120310A (enExample)
NO (1) NO983991L (enExample)
NZ (1) NZ331484A (enExample)
PL (1) PL328875A1 (enExample)
PT (1) PT886647E (enExample)
RU (1) RU2178419C2 (enExample)
TR (1) TR199801704T2 (enExample)
TW (1) TW442452B (enExample)
WO (1) WO1997031937A1 (enExample)
ZA (1) ZA971667B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU719216B2 (en) * 1996-02-13 2000-05-04 Akzo Nobel N.V. Serine protease inhibitors
JP2001525823A (ja) 1997-05-15 2001-12-11 イーライ・リリー・アンド・カンパニー 抗血栓化合物
KR20010043004A (ko) 1998-04-30 2001-05-25 개리 이. 프라이드만 피코르나 바이러스 억제 화합물, 그의 제조 방법 및 용도
EP1105412A1 (en) * 1998-08-17 2001-06-13 Cortech, Inc. Serine protease inhibitors comprising alpha-keto heterocycles
AU3731400A (en) 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
US6849605B1 (en) 1999-03-05 2005-02-01 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
US6489308B1 (en) 1999-03-05 2002-12-03 Trustees Of University Of Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of nitric-oxide-induced clinical conditions
CN1372566A (zh) 1999-08-04 2002-10-02 阿格罗尼制药公司 抗细小核糖核酸病毒的化合物和组合物,它们的药物用途,及其合成原料
NZ523134A (en) 2000-06-14 2004-08-27 Agouron Pharma Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
US7244721B2 (en) 2000-07-21 2007-07-17 Schering Corporation Peptides as NS3-serine protease inhibitors of hepatitis C virus
WO2002008187A1 (en) 2000-07-21 2002-01-31 Schering Corporation Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
MXPA03000627A (es) 2000-07-21 2004-07-30 Schering Corp Nuevos peptidos como inhibidores de proteasa serina-ns3 del virus de la hepatitis c.
HUP0304058A2 (hu) 2001-01-30 2004-04-28 Bristol-Myers Squibb Company Xa faktor szulfonamid-laktám inhibitorok és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
US7405210B2 (en) * 2003-05-21 2008-07-29 Osi Pharmaceuticals, Inc. Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
ES2353309T3 (es) 2004-03-08 2011-03-01 Prosidion Ltd. Hidrazidas del ácido pirrolopiridin-2-carboxílico como inhibidores de glucógeno fosforilasa.
ATE424821T1 (de) 2004-12-02 2009-03-15 Prosidion Ltd Pyrrolopyridin-2-karbonsäureamide
RU2509776C2 (ru) * 2008-10-15 2014-03-20 ДАНИСКО ЮЭс ИНК. МОДИФИЦИРОВАННЫЕ ВАРИАНТЫ ИНГИБИТОРОВ ПРОТЕАЗ Bowman Birk
EP4257191A3 (en) 2016-06-21 2023-11-22 Orion Ophthalmology LLC Heterocyclic prolinamide derivatives
WO2017222914A1 (en) 2016-06-21 2017-12-28 Inception 4, Inc. Carbocyclic prolinamide derivatives
WO2022013684A1 (en) 2020-07-11 2022-01-20 Pfizer Inc. Antiviral heteroaryl ketone derivatives
US11351149B2 (en) 2020-09-03 2022-06-07 Pfizer Inc. Nitrile-containing antiviral compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556655A (en) * 1984-09-24 1985-12-03 Schering Corporation Antihypertensive compounds having both diuretic and angiotensin converting enzyme inhibitory activity
CA2008116C (en) * 1989-02-23 2001-11-20 Thomas Weller Glycine derivatives
ZW11290A1 (en) 1989-07-14 1990-10-31 Smithkline Beecham Corp Hemoregulatory peptides
US5672582A (en) * 1993-04-30 1997-09-30 Merck & Co., Inc. Thrombin inhibitors
WO1994025051A1 (en) * 1993-04-30 1994-11-10 Merck & Co., Inc. Thrombin inhibitors
SE9301916D0 (sv) 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
ZA951618B (en) 1994-03-04 1996-08-27 Lilly Co Eli Antithrombotic agents
ZA951617B (en) 1994-03-04 1997-02-27 Lilly Co Eli Antithrombotic agents.
US5561146A (en) 1994-06-10 1996-10-01 Bristol-Myers Squibb Company Modified guanidino and amidino thrombin inhibitors
JPH10503176A (ja) * 1994-06-17 1998-03-24 コーバス インターナショナル, インコーポレイテッド 酵素インヒビターとしての3−アミノ−2−オキソ−1−ピペリジン酢酸誘導体
JPH0820597A (ja) * 1994-07-07 1996-01-23 Meiji Seika Kaisha Ltd トロンビン阻害作用を有する複素環カルボニル化合物
JPH11508535A (ja) * 1994-12-22 1999-07-27 バイオケム ファーマ インコーポレイテッド 低分子量2環式トロンビン阻害剤

Similar Documents

Publication Publication Date Title
JP2001504701A5 (enExample)
JP2001509036A5 (enExample)
JP2001504330A5 (enExample)
JPH11508439A5 (enExample)
JP2001501216A5 (enExample)
JP2002511982A5 (enExample)
JP2000516626A5 (enExample)
JP2000507766A5 (enExample)
JP2002514060A5 (enExample)
JP2000508361A5 (enExample)
JP2000512180A5 (enExample)
JP2000500055A5 (enExample)
JP2000500026A5 (enExample)
JP2000514136A5 (enExample)
JP2000516489A5 (enExample)
JP2000512184A5 (enExample)
JP2001507225A5 (enExample)
JP2002515107A5 (enExample)
JP2001502861A5 (enExample)
JP2001505864A5 (enExample)
JP2000516978A5 (enExample)
JP2001503778A5 (enExample)
JP2000507828A5 (enExample)
JP2000511888A5 (enExample)
JP2001503802A5 (enExample)